Julie van der Zee’s research focusses on the genetics of frontotemporal dementia and early-onset dementia, aiming at a better understanding of the molecular biology of neurodegenerative dementia to aid improved diagnosis and prognosis of patients, and ultimately to contribute to novel therapeutic approaches. In 2007, she obtained her PhD on the molecular genetics of frontotemporal lobar degeneration, together with Alzheimer’s disease a common cause of early-onset dementia. In 2011, she has co-founded and coordinates, together with Coordinator Christine Van Broeckhoven, the European Early-Onset Dementia Consortium. The consortium brings together expert research groups with a common interest in identifying novel causal, modifying and protective genetic factors of dementia, approaching the research with complementary expertise from basic science to clinical research in neurodegenerative diseases. In 2012, she was appointed Professor in Translational Genetics at the University of Antwerp. In addition to her research activities, she has developed a strong societal engagement to increase the visibility of dementia research to lay people and raise social awareness. She gives regular educative lectures to patient and lay organizations to provide accessible information on progress made in dementia research, give visibility to the research programs and encourage volunteers to participate to research.